Pomerantz LLP Investigates Claims of Securities Fraud Against Neogen Corporation

Pomerantz LLP is conducting an investigation into potential securities law violations by Neogen Corporation, following the company's disclosure of disappointing fourth-quarter financial results. On June 4, 2025, Neogen announced an expected EBITDA margin decline due to elevated inventory write-offs, which caused its stock price to plummet by 17.3% to close at $4.96 per share. Investors who may have suffered losses are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980.

Key Takeaways:

Pomerantz LLP is investigating Neogen Corporation for potential securities law violations, including securities fraud and other unlawful business practices.
The investigation concerns the company's disclosure of disappointing fourth-quarter financial results, which led to a significant decline in its stock price.
Neogen attributed the decline in EBITDA margin to elevated inventory write-offs, which may have been a material misrepresentation of the company's financial condition.
The Pomerantz Firm has a long history of fighting for the rights of victims of securities fraud, breaches of fiduciary duty, and corporate misconduct.
The firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Statistics:

Neogen's stock price fell $1.04 per share, or 17.3%, to close at $4.96 per share on June 4, 2025.
The Pomerantz Firm has recovered over $1 billion in damages awards on behalf of class members over the past 10 years.
Neogen's EBITDA margin is expected to decline to around the high-teens, compared to 22% in the previous quarter.

Sources:

GlobeNewswire, Pomerantz LLP Announces Investigation of Neogen Corporation.
Pomerantz LLP Securities Class Action Law Firm website, [www.pomlaw.com](http://www.pomlaw.com).
Legal Monitor Worldwide, "Pomerantz LLP Investigates Claims of Securities Fraud Against Neogen Corporation".
Pomerantz LLP, Attorney Advertising.
Seewww.pomerantzlaw.com.